#ATTR News: Today we open a #NewEraOfMedicine. We’re proud to announce the first clinical data suggesting a single infusion of #CRISPR may potently and precisely inactivate a disease-causing gene, opening the door to treating, reversing or curing previously inaccessible diseases.
A great example of how #COVID19 has pushed us all to build a more connected health care system, supported by @Optum virtual care, that advances holistic health. ⬇️
Health is deeply influenced by external factors. We are working to expand access to care, driving greater #HealthEquity for underserved & uninsured populations. More → https://t.co/7JsyRIt9hh
Intellia is honored to be recognized as one of the 15 biotech companies on @Forbes' list of America’s Best Mid-Size Companies of 2021. We are humbled to share this title with other prestigious organizations – congratulations to all! https://t.co/YDEWZHv7ZS #CRISPR#genomeediting
I am praying for the United States of America, shaken by the recent attack on Congress. I pray for those who lost their life. Violence is always self-destructive. I urge everyone to promote a culture of encounter and of care to construct the common good.
Congratulations to our colleagues who reached their five and six year anniversary at Intellia! Thank you for your hard work and diligence to help bring potentially curative #genomeediting treatments to patients in need. #ONEIntellia#IamIntellia#CRISPR
Check out the full news segment of Intellia President and CEO, John Leonard, M.D., on @WCVB with @EmilyWCVB discussing how Intellia is investigating #CRISPR in our first clinical trial: https://t.co/YsAgMGV5vg #genomeediting#RoadtotheClinic
Another big announcement from $NTLA today! We’ve received a @gatesfoundation grant to develop curative #CRISPR /Cas9 in vivo #sicklecelldisease treatments. 🧬 Read the press release➡️https://t.co/fJOQMhbOvX #conquerSCD
We’re pleased to announced that $NTLA received authorization of its Clinical Trial Application by @MHRAgovuk to initiate a global Phase 1 clinical trial of NTLA-2001 for the treatment of #ATTR. Full press release here: https://t.co/A1Cl9gBPLB #genomeediting
We’re pleased to announced that $NTLA received authorization of its Clinical Trial Application by @MHRAgovuk to initiate a global Phase 1 clinical trial of NTLA-2001 for the treatment of #ATTR. Full press release here: https://t.co/A1Cl9gBPLB #genomeediting
We’re launching our #RoadtotheClinic series to highlight a few of the milestones – and our colleagues – propelling Intellia toward our first clinical trial this year. #CRISPR#genomeediting#OneIntellia
🎶 Here’s some Rambler spirit from Loyola Band to start your week! Members of the band came together to share recordings of themselves playing at home so they could have one more performance together.
#goramblers@LAGoRamblers
Support my birthday fundraiser and help me reach my goal of $2,500! Donate to @headstrongproj to support their important mission of caring for the mental health of veterans. It is especially important during the COVID-19 crisis. https://t.co/uiqNOfSzEd